Norcliffe Capital

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies

1 Jul 2025

Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies

Laverock Therapeutics is developing programmable gene control technologies that enable advanced therapies to respond dynamically to disease, improving precision, safety and effectiveness in cell-based treatments.

Norcliffe Capital

- Life Sciences
norcliffe.capital
Update Information

More venture news

AI Score
4 Sept 2026
AI Score lands a £4m seed round led by Fuel Ventures to track and control AI usage within organisations
SeedAI
Ki 13
2 Sept 2026
Ki 13 unlocks a £3.7m seed round led by HICO Investment Group to make green hydrogen and CO₂ from biomass
SeedEnergy
Orchestra
1 Sept 2026
Orchestra lands a £2.4m seed round led by Differential Ventures for control plane that runs data pipelines and AI agents together
SeedDeveloper Tools

Norcliffe Capital

Investment Portfolio

Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies

More venture news

AI Score lands a £4m seed round led by Fuel Ventures to track and control AI usage within organisations

Ki 13 unlocks a £3.7m seed round led by HICO Investment Group to make green hydrogen and CO₂ from biomass

Orchestra lands a £2.4m seed round led by Differential Ventures for control plane that runs data pipelines and AI agents together